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Editorials

Self-sampling HPV testing versus
mainstream cervical screening and
HPV testing

A

comprehensive review of Australia’s National
Cervical Screening Program (NCSP), the Renewal,
has been undertaken over the past few years.1 This
review recommended a number of changes, including
that human papillomavirus (HPV) testing replace conventional cytology (ie, Pap tests) as the primary screening
test, with 5-yearly screening commencing at age 25. The
proposals have been endorsed by the Medical Services
Advisory Committee (MSAC).2

“the test result
can be affected
by the nature
of the sample
and the type of
HPV testing”
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The Renewal deliberations also considered the question
of the recruitment of women who had never been
screened or who were underscreened, a significant
concern because it has been estimated that 80% of
cervical cancers are diagnosed in these women.1 One
proposed solution is to offer a separate self-sampling
HPV testing pathway, as studies, both in Australia3 and
internationally,4 have shown self-sampling to increase
recruitment and to be advantageous in underscreened
women. The Renewal proposal is that the self-sampling
option be organised by a clinician who also offers routine
screening. It would be offered to women who have not
been screened during the previous 6 years, or who have
never been screened and have declined to participate in
the mainstream screening pathway. The sample would
be taken by the patient, possibly in the clinic, and sent
to the laboratory for testing. If the sample is positive
for HPV, the patient would be asked to return to give a
cytology sample.
This edition of the MJA includes the report on a study
by Smith and colleagues that compared the benefits
of self-sampling HPV testing with the mainstream
screening program.5 One consideration for the NCSP
was that offering two different screening options might
cause confusion. Some women who normally undergo
screening may even prefer the self-sampling option. Smith
and colleagues, using a dynamic modelling approach,
clearly established that self-sampling is associated with
a lower risk of a cervical cancer diagnosis than not being
screened. However, it also found that HPV testing as part
of the recommended mainstream screening program
has clear advantages over the self-sampling pathway,
and that women should avail themselves of this option.
The importance of education and communication is well
illustrated by the self-sampling question. Self-sampling
has already received quite significant publicity in
mainstream media; however, there appear to be many
misconceptions. Many of the reports, for example, imply
that self-sampling was the only significant change
recommended and that it is significantly beneficial.
Headlines such as “Australian women will be able
to do their own Pap smear”6 and “You could soon be

doing your own Pap smear”7 have appeared online. Such
comments are confusing and misleading for both the
general public and the medical profession. The study by
Smith and colleagues is therefore important, as it clearly
establishes that there are two different testing pathways
to be preferred under different circumstances.
This difference in the two pathways also highlights
how the test result can be affected by the nature of
the sample and the type of HPV testing. At the last
count, more than 500 different types of HPV testing are
available worldwide. The technology of HPV testing is
complex and variable, and, until the commencement of
the new program, will have predominantly been used
as a diagnostic rather than a screening test. Validated
assays that assure high quality screening must be used.
A recent article suggested that only HPV tests that have
been subjected to large randomised trials with a long
cohort follow-up be used.8 The Netherlands has recently
introduced HPV self-sampling as the primary screening
test, but, unlike Australia, has designated one specific
type of high risk HPV assay for use.9
The Australian Renewal recommends that any type of
HPV test can be used, but that the test must meet certain
quality criteria. The study by Smith and colleagues points
out that, although self-sampling has been shown to be
beneficial, it is dependent on the nature of the HPV assay.
Specific quality standards for self-sampling HPV testing
will need to be set. The National Pathology Accreditation
Advisory Council (NPAAC) is in the process of setting
quality parameters for HPV testing and will consider
the criteria for the two pathways.10 Laboratories will
be left to choose which type of HPV test they perform,
but the testing will have to fulfil the quality standards
mandated by NPAAC.
The proposed changes to cervical screening are major
and will need accurate and concise information to be
distributed to both sample takers and women. The
message from Smith and her colleagues is quite clear:
self-sampling offers an alternative pathway for women
who will not participate in routine screening, but it is
significantly less beneficial than mainstream cervical
screening. For both screening pathways, the quality of the
HPV assay will be crucial to the success of the program
and the safety of women.
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